-20℃ 3 years powder
-80℃ 2 years in solvent
TAK-828F is a potent, selective, and orally available retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonist (IC50=1.9 nM, reporter gene IC50=6.1 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | inquiry | inquiry | |
500 mg | inquiry | inquiry |
Description | TAK-828F is a potent, selective, and orally available retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonist (IC50=1.9 nM, reporter gene IC50=6.1 nM). |
Targets&IC50 | RORγt, binding IC50 :ic50 1.9 nM, RORγt, reporter gene IC50 :ic50 6.1 nM, |
In vivo | In mice with IL-23-induced cytokine expression model, TAK-828F (0.3, 1, and 3 mg/kg; orally administered; b.i.d.; 28 days; ) shows robust and dose-dependent inhibition of IL-17A expression with an ED80 of 0.5 mg/kg. |
Molecular Weight | 509.57 |
Formula | C28H32FN3O5 |
CAS No. | 1854901-94-2 |
-20℃ 3 years powder
-80℃ 2 years in solvent
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.